The Effects of Dipeptidyl Peptidase-4 Inhibitors in Treatment of Obese Patients with Type 2 Diabetes-Reference-Cited by-同舟云学术

The Effects of Dipeptidyl Peptidase-4 Inhibitors in Treatment of Obese Patients with Type 2 Diabetes

Published:2013 Issue:5 Volume:67 Page:365
ISSN:0350-199X
Container-title:Medical Archives
language:
Short-container-title:Med Arh

Author:

VelijaAsimi Zelija,Izetbegovic Sebija,Karamehic Jasenko,Coric Jozo,Panjeta Mirsad,MacicDzankovic Amra,DjelilovicVranic Jasminka,mela DizdarevicBostandzic mela DizdarevicBostandzic

Publisher

ScopeMed

Subject

General Medicine

Link

http://www.scopemed.org/fulltextpdf.php?mno=46177

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dipeptidyl-peptidase 4 (DPP4) mediates fatty acid uptake inhibition by glucose via TAS1R3 and GLUT-2 in Caco-2 enterocytes;Heliyon;2024-05

2. Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2022-06

3. Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME‐V study);Journal of Diabetes Investigation;2020-08-20

4. Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open‐label, blinded‐endpoint, randomized controlled study (PRIME‐V study);Diabetes, Obesity and Metabolism;2019-08

5. Impact of exercise training on dipeptidyl peptidase 4 and insulin-like growth factor binding protein 1 in patients with coronary artery disease: Relationship to nitric oxide response;Acta Facultatis Medicae Naissensis;2019